Literature DB >> 21617785

The impact of liquid-based cytology in decreasing the incidence of cervical cancer.

Randall K Gibb, Mark G Martens.   

Abstract

Major advances in screening have lowered the death rate from cervical cancer in the United States. One of the first major advances in cervical cancer screening was the Papanicolaou (Pap) test. The second major advance was liquid-based cytology (LBC). This review presents a wide range of data, discusses the strengths and weaknesses of the available information regarding Pap technologies, and reviews the meta-analyses, which have examined the differences in clinical performance. The review concludes with information on new and future developments to further decrease cervical cancer deaths.

Entities:  

Keywords:  Cervical cancer detection; Liquid-based cytology; Papanicolaou test

Year:  2011        PMID： 21617785      PMCID： PMC3101960     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN： 1941-2797


  43 in total

1.  Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".

Authors:  George F Sawaya
Journal:  Arch Intern Med       Date:  2010-06-14

2.  ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

3.  ThinPrep Pap Test. Accuracy for glandular disease.

Authors:  R Ashfaq; D Gibbons; C Vela; M H Saboorian; F Iliya
Journal:  Acta Cytol       Date:  1999 Jan-Feb       Impact factor: 2.319

4.  Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.

Authors:  K R Lee; R Ashfaq; G G Birdsong; M E Corkill; K M McIntosh; S L Inhorn
Journal:  Obstet Gynecol       Date:  1997-08       Impact factor: 7.661

5.  Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Authors:  Mark H Einstein; Mark G Martens; Francisco A R Garcia; Daron G Ferris; Amy L Mitchell; Stephen P Day; Marilyn C Olson
Journal:  Gynecol Oncol       Date:  2010-05-21       Impact factor: 5.482

6.  ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.

Authors:  H Bai; C J Sung; M M Steinhoff
Journal:  Diagn Cytopathol       Date:  2000-07       Impact factor: 1.582

Review 7.  Cancer of the uterine cervix.

Authors:  S A Cannistra; J M Niloff
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

8.  Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.

Authors:  Joy Melnikow; Shalini Kulasingam; Christina Slee; L Jay Helms; Miriam Kuppermann; Stephen Birch; Colleen E McGahan; Andrew Coldman; Benjamin K S Chan; George F Sawaya
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

9.  Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.

Authors:  Galen M Eversole; Ann T Moriarty; Mary R Schwartz; Amy C Clayton; Rhona Souers; Lisa A Fatheree; Beth A Chmara; William D Tench; Michael R Henry; David C Wilbur
Journal:  Arch Pathol Lab Med       Date:  2010-03       Impact factor: 5.534

10.  Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Journal:  BMJ       Date:  2009-07-28
View more
  16 in total

Review 1.  Old drug, new trick: repurposing metformin for gynecologic cancers?

Authors:  Terri Febbraro; Ernst Lengyel; Iris L Romero
Journal:  Gynecol Oncol       Date:  2014-10-23       Impact factor: 5.482

2.  Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.

Authors:  Margaret Z Wang; Rui-Mei Feng; Shaoming Wang; Xian-Zhi Duan; Dong Li; Xun Zhang; Rong Mu; Youlin Qiao; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2019-08       Impact factor: 2.830

3.  Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning.

Authors:  Jing Ke; Yiqing Shen; Yizhou Lu; Junwei Deng; Jason D Wright; Yan Zhang; Qin Huang; Dadong Wang; Naifeng Jing; Xiaoyao Liang; Fusong Jiang
Journal:  Lab Invest       Date:  2021-02-01       Impact factor: 5.662

4.  Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.

Authors:  Diane M Harper
Journal:  J Clin Oncol       Date:  2022-05-20       Impact factor: 50.717

Review 5.  Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?

Authors:  Mohammed Amer Swid; Sara E Monaco
Journal:  Mod Pathol       Date:  2022-03-07       Impact factor: 8.209

Review 6.  Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2015-11-20       Impact factor: 3.452

7.  Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix.

Authors:  Richa Tripathi; Gayatri Rath; Poonam Jawanjal; Shweta Sharma; Pallavi Singhal; Suresh Bhambhani; Showket Hussain; Mausumi Bharadwaj
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.752

8.  Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.

Authors:  Adrya Lúcia Peres; Keilla Maria Paz E Silva; Rosângela Ferreira Frade de Araújo; José Luiz de Lima Filho; Mário Ribeiro de Melo Júnior; Danyelly Bruneska Gondim Martins; Nicodemos Teles de Pontes Filho
Journal:  J Biomed Sci       Date:  2016-05-12       Impact factor: 8.410

9.  Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.

Authors:  Rebecca Luckett; Neo Mogowa; Howard J Li; Adrienne Erlinger; Michele R Hacker; Katharine Esselen; Sarah Feldman; Roger Shapiro; Chelsea Morroni; Doreen Ramogola-Masire
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

10.  Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.

Authors:  Pamela Moussavou-Boundzanga; Ismaël Hervé Koumakpayi; Ingrid Labouba; Eric M Leroy; Ernest Belembaogo; Nicolas Berthet
Journal:  Virol J       Date:  2017-12-21       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.